ES2155566T3 - Uso de derivados de rifamicina para el tratamiento de enfermedades infecciosas por clamidia. - Google Patents
Uso de derivados de rifamicina para el tratamiento de enfermedades infecciosas por clamidia.Info
- Publication number
- ES2155566T3 ES2155566T3 ES96119613T ES96119613T ES2155566T3 ES 2155566 T3 ES2155566 T3 ES 2155566T3 ES 96119613 T ES96119613 T ES 96119613T ES 96119613 T ES96119613 T ES 96119613T ES 2155566 T3 ES2155566 T3 ES 2155566T3
- Authority
- ES
- Spain
- Prior art keywords
- clamidia
- treatment
- group
- infectious diseases
- rifamycin derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
TRATAMIENTO DE ENFERMEDADES CAUSADAS POR INFECCION DE CLAMIDIA MEDIANTE UN DERIVADO DE RIFAMICINA DE LA FORMULA (I): SIENDO R{SUP,1} UN ATOMO DE HIDROGENO O UN GRUPO ACETIL, Y X UN ATOMO DE OXIGENO, UN ATOMO DE SULFURO O UN GRUPO NR EN EL QUE R ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUIL QUE TIENE DE 1 A 7 ATOMOS DE CARBONO O UN GRUPO DE LA FORMULA (II): EN LA QUE N ES UN INTEGRO DE 1 A 3; O UN COMPUESTO SALINO DE LA MISMA ACEPTABLE FISIOLOGICAMENTE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32088295 | 1995-12-08 | ||
JP00263496A JP3963976B2 (ja) | 1995-12-08 | 1996-01-10 | クラミジア感染症治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2155566T3 true ES2155566T3 (es) | 2001-05-16 |
Family
ID=26336071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96119613T Expired - Lifetime ES2155566T3 (es) | 1995-12-08 | 1996-12-06 | Uso de derivados de rifamicina para el tratamiento de enfermedades infecciosas por clamidia. |
Country Status (6)
Country | Link |
---|---|
US (1) | US5786349A (es) |
EP (1) | EP0778022B1 (es) |
JP (1) | JP3963976B2 (es) |
CA (1) | CA2192255C (es) |
DE (1) | DE69612465T2 (es) |
ES (1) | ES2155566T3 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006328080A (ja) * | 1995-12-08 | 2006-12-07 | Kaneka Corp | クラミジア感染症治療剤 |
US6316433B1 (en) * | 1998-12-18 | 2001-11-13 | Kaneka Corporation | Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
US6900204B2 (en) * | 2001-09-06 | 2005-05-31 | Activbiotics, Inc. | Antimicrobial agents and uses thereof |
JP2005510534A (ja) * | 2001-11-21 | 2005-04-21 | アクティブバイオティクス インコーポレイティッド | 標的化治療薬およびその使用 |
WO2003051299A2 (en) * | 2001-12-13 | 2003-06-26 | Activbiotics, Inc. | Sulfhydryl rifamycins and uses thereof |
US20040077533A1 (en) * | 2002-05-23 | 2004-04-22 | Sayada Chalom B. | Methods and compositions for treating bacterial infections and diseases associated therewith |
CA2490062A1 (en) * | 2002-05-23 | 2003-12-04 | Activbiotics, Inc. | Methods of treating bacterial infections and diseases associated therewith |
US20090149453A1 (en) * | 2002-05-23 | 2009-06-11 | Activbiotics Pharma Llc | Methods and compositions for treating bacterial infections and diseases associated therewith |
TW200418485A (en) * | 2002-09-23 | 2004-10-01 | Activbiotics Inc | Rifalazil compositions and therapeutic regimens |
WO2004054513A2 (en) * | 2002-12-12 | 2004-07-01 | Activbiotics, Inc. | Methods and compositions for treating and preventing ear infections |
US20040176404A1 (en) * | 2002-12-12 | 2004-09-09 | Sayada Chalom B. | Methods and reagents for treating or preventing atherosclerosis and diseases associated therewith |
WO2005020894A2 (en) * | 2003-08-22 | 2005-03-10 | Activbiotics, Inc. | Rifamycin analogs and uses thereof |
US7820652B2 (en) * | 2003-09-24 | 2010-10-26 | Activbiotics Pharma, Llc | Regimen for the administration of rifamycin-class antibiotics |
CA2538078C (en) * | 2003-09-25 | 2012-12-04 | Activbiotics, Inc. | Rifalazil formulations |
WO2005058231A2 (en) * | 2003-12-10 | 2005-06-30 | Activbiotics, Inc. | Rifamycin analogs and uses thereof |
CA2550729A1 (en) * | 2003-12-23 | 2005-07-14 | Activbiotics, Inc. | Rifamycin analogs and uses thereof |
US20070248668A1 (en) * | 2006-04-06 | 2007-10-25 | Michaelis Arthur F | Pharmaceutical compositions and uses thereof |
WO2007148714A1 (ja) * | 2006-06-21 | 2007-12-27 | Kaneka Corporation | リファマイシン誘導体を用いたインプラント |
WO2007148713A1 (ja) * | 2006-06-21 | 2007-12-27 | Kaneka Corporation | リファマイシン誘導体を有効成分とする血管性疾患処置剤または細胞増殖調節剤 |
SI3004162T1 (sl) | 2013-05-31 | 2020-07-31 | Genentech, Inc. | Protitelesa in konjugati, ki so usmerjeni proti celični steni bakterij, v kateri je teihoična kislina |
US9803002B2 (en) | 2013-05-31 | 2017-10-31 | Genentench, Inc. | Anti-wall teichoic antibodies and conjugates |
CA2913011A1 (en) | 2013-05-31 | 2014-12-04 | Genentech, Inc. | Anti-wall teichoic antibodies and conjugates |
US20170196917A1 (en) | 2014-05-15 | 2017-07-13 | Kabushiki Kaisha Yakult Honsha | Agent for prevention and treatment of chlamydia infection |
RU2731055C2 (ru) | 2014-12-03 | 2020-08-28 | Дженентек, Инк. | Конъюгаты антитела к staphylococcus aureus с рифамицином и их применение |
CA2966211A1 (en) | 2014-12-03 | 2016-06-09 | Genentech, Inc. | Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4690919A (en) * | 1984-01-04 | 1987-09-01 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same |
JPS61128621A (ja) | 1984-11-27 | 1986-06-16 | Rohm Co Ltd | フリツプフロツプ回路 |
JPS63183587A (ja) | 1985-02-05 | 1988-07-28 | Kanegafuchi Chem Ind Co Ltd | ベンゾキサジノリフアマイシン誘導体 |
CA1304363C (en) * | 1988-11-01 | 1992-06-30 | Takehiko Yamane | 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same |
JP2544488B2 (ja) * | 1988-11-01 | 1996-10-16 | 鐘淵化学工業株式会社 | 3’―ヒドロキシベンゾキサジノリファマイシン誘導体 |
JP2862912B2 (ja) * | 1989-09-14 | 1999-03-03 | 鐘淵化学工業株式会社 | 5’―(4―プロピルまたは4―イソプロピルピペラジニル)ベンゾキサジノリファマイシン誘導体 |
-
1996
- 1996-01-10 JP JP00263496A patent/JP3963976B2/ja not_active Expired - Fee Related
- 1996-12-06 DE DE69612465T patent/DE69612465T2/de not_active Expired - Lifetime
- 1996-12-06 CA CA002192255A patent/CA2192255C/en not_active Expired - Fee Related
- 1996-12-06 ES ES96119613T patent/ES2155566T3/es not_active Expired - Lifetime
- 1996-12-06 EP EP96119613A patent/EP0778022B1/en not_active Expired - Lifetime
- 1996-12-09 US US08/762,501 patent/US5786349A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69612465D1 (de) | 2001-05-17 |
EP0778022B1 (en) | 2001-04-11 |
JP3963976B2 (ja) | 2007-08-22 |
CA2192255A1 (en) | 1997-06-09 |
DE69612465T2 (de) | 2001-08-23 |
EP0778022A1 (en) | 1997-06-11 |
CA2192255C (en) | 2004-07-13 |
US5786349A (en) | 1998-07-28 |
JPH09216824A (ja) | 1997-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2155566T3 (es) | Uso de derivados de rifamicina para el tratamiento de enfermedades infecciosas por clamidia. | |
CO4410321A1 (es) | Compuestos ciclicos condensados con funciones aminoacidas sustituidas y derivados ester de los mismos | |
ES2190469T3 (es) | Derivados de isocumarina y su uso en farmacos. | |
ES2194314T3 (es) | Derivados de benzopirano sustituidos para el tratamiento de inflamaciones. | |
ES2174989T3 (es) | Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion. | |
ES2143526T3 (es) | Derivados de amida que tienen actividad antihipercolesterolemica, su preparacion y sus usos terapeuticos. | |
HUP0000343A2 (hu) | 1,3-Propándiol-származékok alkalmazása szervátültetés után fellépő kilökődés megakadályozására | |
ES2095772T3 (es) | Utilizacion de derivados de rifamicina para producir un medicamento destinado al tratamiento de la toxoplasmosis. | |
NZ334848A (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases caused by fungi and bacteria | |
ES2182114T3 (es) | Derivados azabiciclicos de la carbamoiloxi-multilina para empleo antibacteriano. | |
MD1560F2 (en) | Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses. | |
AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. | |
DE3869075D1 (de) | 2-piperazinyl-2-oxo-aethylensubstituierte flavonoid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
DE69423339D1 (de) | Epoxycyclohexendionderivat | |
BG103271A (en) | Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means | |
KR960003719A (ko) | 녹내장 치료제 및 안압 강하제 | |
PT89082A (pt) | Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico | |
KR960703843A (ko) | 아실페닐글리신 유도체 및 그 화합물을 유효성분으로 하는, 콜라게나제 활성증진에 기인한 질환의 예방 및 치료 제(acylphenylglycine derivative and preventive and remedy for diseases caused by increased collagenase activity containing said compound as active ingredient) | |
DE69533298D1 (de) | Dioxabicyclo 3.3.0 octan-Derivate, z.B. Sesamin etc., zur Vorbeugung und Erleichterung von Allergiesymptomen | |
ATE184282T1 (de) | Cyclopropan-derivate und diese enthaltende antivirale mittel | |
DE69519895D1 (de) | Pyrimidinderivate und pharmazeutische Zusammensetzungen | |
KR920702685A (ko) | 4,6-o- 히드록시포스포릴글루코사민 유도체 | |
AR034088A1 (es) | Composicion que comprende derivados anticonvulsivantes utiles en el tratamiento de esquizofrenia y el uso de dicho derivado para la manufactura de un medicamento | |
ES2096800T3 (es) | Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 778022 Country of ref document: ES |